Wall Street RegretsThe regret calculator.

What if you'd held CORT?

A $1,000 investment in Corcept Therapeutics Incorporated (CORT) at the month-end close of 2004-04 would be worth $10,138 at the close of 2026-08 — +913.8% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $6,961.

$1,000 since 2004$10,138Total return+913.8%Multiple10.1×CAGR+10.9%

Your scenario

Dates resolve to the nearest month-end close.
Leave empty for "held until today".
Invested at each month-end. Starts on the buy date.

Result

Worth$10,138Gain+$9,138 (+913.8%)Multiple10.1×CAGR+10.9%

    If you'd bought $1,000 at the start of each year

    Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.

    2004$10,1382005$19,0432006$32,6082007$96,7642008$38,5182009$116,6862010$42,8132011$30,8342012$34,8012013$83,2312014$37,0782015$39,6732016$23,9002017$16,3942018$6,5902019$8,9092020$9,8362021$4,5502022$6,0112023$5,8602024$3,6642025$2,3622026$3,420

    Every year, $1,000 from 2004

    YearValue of $1,000Year return
    2004$1,000
    2005$584-41.6%
    2006$197-66.3%
    2007$494+151.2%
    2008$163-67.0%
    2009$445+172.5%
    2010$618+38.8%
    2011$547-11.4%
    2012$229-58.2%
    2013$514+124.5%
    2014$480-6.5%
    2015$797+66.0%
    2016$1,162+45.8%
    2017$2,890+148.8%
    2018$2,138-26.0%
    2019$1,936-9.4%
    2020$4,186+116.2%
    2021$3,168-24.3%
    2022$3,250+2.6%
    2023$5,197+59.9%
    2024$8,062+55.1%
    2025$5,568-30.9%
    2026$19,043+242.0%

    Best and worst month-end to buy

    The best single month-end close to have bought CORT was 2006-10 ($0.80): $1,000 then is $148,775 today. The worst was 2026-08 ($119): $1,000 then is $1,000.

    FAQ

    What would $1,000 in CORT be worth today?

    A $1,000 investment in Corcept Therapeutics Incorporated (CORT) at the start of 2004 would be worth about $10,138 today, a total return of +913.8%. Dividends are reinvested in these figures.

    What were the best and worst years for CORT?

    Corcept Therapeutics Incorporated (CORT)'s strongest calendar year since 2004 was 2026, a +242.0% return — $1,000 held through that year became about $3,420 by year-end. Its weakest year was 2008, at -67.0%.

    Does the calculator include dividends and splits?

    Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.

    How much would $100 per month in CORT have grown?

    Investing $100 at the end of every month since 2004-04 would have grown to about $789,929 on $26,900 invested.

    Did CORT beat the S&P 500?

    Over the same period, $1,000 in the S&P 500 index would be worth $6,961. CORT beat the S&P 500 by +45.6% in total return.

    Is this investment advice?

    No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.

    Methodology

    Corcept Therapeutics Incorporated (CORT) historical total-return data from 2004-04 to 2026-08, reduced to month-end closes for the tables above.

    Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.

    Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.

    Full methodology →

    What if you'd held…

    Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.